58859-66-8 Usage
Description
3-[Benzyl-(2-ethoxycarbonyl)hydrazono]-5-methyl-1-phenyl-1H-pyrazole-4-carboxylic acid ethyl ester, commonly known as BEMPP, is a pyrazole derivative featuring a benzyl and an ethyl ester group attached to its core structure. 3-[Benzyl-(2-ethoxycarbon... has garnered interest due to its potential pharmacological applications, including anti-inflammatory, analgesic, and antimicrobial properties. It is also being studied for its potential as a COX-2 inhibitor and for treating other conditions, although further research is necessary to fully elucidate its pharmacological profile and potential uses.
Uses
Used in Pharmaceutical Industry:
BEMPP is used as a potential anti-inflammatory agent for reducing inflammation in various conditions. Its anti-inflammatory properties are attributed to its ability to modulate inflammatory pathways, providing relief from symptoms associated with inflammation.
Used in Pain Management:
As an analgesic, BEMPP is utilized for the management of pain. Its efficacy in alleviating pain is likely due to its interaction with pain signaling pathways, offering a potential alternative or adjunct to existing pain management therapies.
Used in Antimicrobial Applications:
BEMPP serves as a potential antimicrobial agent, useful in combating bacterial infections. Its antimicrobial activity may be due to its ability to disrupt essential bacterial processes, thereby inhibiting their growth and spread.
Used in COX-2 Inhibition:
As a potential COX-2 inhibitor, BEMPP is being explored for its use in treating conditions that involve the overexpression of COX-2 enzymes, such as certain types of pain and inflammation. By inhibiting COX-2, BEMPP may help reduce inflammation and associated pain without the side effects often associated with non-selective COX inhibitors.
Used in Other Therapeutic Applications:
While still under investigation, BEMPP may have potential uses in treating other conditions, depending on the outcomes of ongoing research. Its diverse pharmacological properties suggest that it could be a candidate for various therapeutic applications once its full potential is understood.
Check Digit Verification of cas no
The CAS Registry Mumber 58859-66-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,8,5 and 9 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 58859-66:
(7*5)+(6*8)+(5*8)+(4*5)+(3*9)+(2*6)+(1*6)=188
188 % 10 = 8
So 58859-66-8 is a valid CAS Registry Number.
58859-66-8Relevant articles and documents
Derives alkyles et aryles de l'acide nipecotique: synthese et appreciation de l'activite inhibitrice de la capture du GABA en fonction de parametres conformationnels et de biodisponibilite
Lapuyade, Gerard,Schlewer, Gilbert,N'Goka, Victor,Vernieres, Jean-Claude,Chambon, Jean-Pierre,et al.
, p. 383 - 392 (2007/10/02)
Alkyl and aryl derivatives of nipecotic acid: synthesis and inhibition of GABA uptake as a function of conformational parameters and bioavailability.Analogs of nipecotic acid, substituted at positions 2, 3, 4, 5, or 6 with a methyl or phenyl group were pr
